Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the month of September 2025, with a specific reporting date of September 10, 2025. The document serves as a notification and public disclosure under the UK Market Abuse Regulation regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs). Haleon operates as a global leader in consumer health with a portfolio spanning oral health, vitamins, pain relief, respiratory health, digestive health, and therapeutic skin health.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory disclosure of insider share transactions. The only financial figures present relate to the specific share transactions detailed below:
- Share Price: £3.6182 per Ordinary Share.
- Transaction Volume: 34 Partnership Shares acquired and 34 Matching Shares awarded per executive.
- Total Volume per Executive: 68 shares.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details routine equity compensation events for two executives under the Company's Share Reward Plan, occurring on September 9, 2025, on the London Stock Exchange (XLON).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a compliance filing solely intended to disclose the following transactions:
- Adrian Morris (General Counsel): Acquired 34 Partnership Shares at £3.6182 and received 34 Matching Shares at no cost.
- Tamara Rogers (Chief Marketing Officer): Acquired 34 Partnership Shares at £3.6182 and received 34 Matching Shares at no cost.
Investor Verification Checklist
- Verify the current share price of Haleon Plc on the London Stock Exchange to confirm the transaction price of £3.6182.
- Review the company's Share Reward Plan terms to understand the matching share mechanism.
- Confirm the total shareholding of Adrian Morris and Tamara Rogers post-transaction via subsequent filings.
- Note that this filing contains no financial results; refer to the most recent Form 20-F or quarterly earnings release for financial performance.